This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Sunesis Pharmaceuticals Inc (SNSS)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 15.12M 14.94M 9.31M 14.22M
Receivables 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 40.49M 72.93M 45.66M 54.68M
Property, Plant & Equipment, Gross 23.00K 43.00K 1.34M 1.95M
Accumulated Depreciation & Depletion 0.00 0.00 1.27M 1.84M
Property, Plant & Equipment, Net 23.00K 43.00K 74.00K 116.19K
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 10.00K 42.00K 130.00K 59.97K
Total Non-Current Assets 33.00K 85.00K 204.00K 176.16K
Liabilities & Shareholder Equity
Total Assets 40.52M 73.02M 45.87M 54.86M
Accounts Payable 953.00K 78.00K 658.00K 415.80K
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 7.93M 8.07M 2.28M 8.15M
Total Current Liabilities 33.97M 31.74M 8.38M 12.56M
Long Term Debt 9.02M 17.65M 9.45M 0.00
Deferred Income Taxes 0.00 0.00 13.00K 47.84K
Other Non-Current Liabilities 3.71M 11.67M 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 12.74M 29.32M 9.47M 47.84K
Total Liabilities 46.71M 61.06M 17.85M 12.61M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity -6.18M 11.96M 28.02M 42.25M
Common Par 5.00K 5.00K 5.00K 4.54K
Additional Paid In Capital 473.51M 457.01M 429.14M 423.26M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -479.70M -445.10M -401.15M -381.01M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -3.00K 38.00K 19.00K -14.73K
Total Capitalization 2.84M 29.61M 37.47M 42.25M
Total Equity -6.18M 11.96M 28.02M 42.25M
Total Liabilities & Stock Equity 40.52M 73.02M 45.87M 54.86M
Total Common Shares Outstanding 54.34M 51.56M 46.77M 45.37M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 52.25M 48.15M 46.41M 24.86M
Diluted Weighted Shares Outstanding 52.25M 48.15M 46.41M 24.86M
Number of Employees 32 25 31 27
Number of Part-Time Employees 0 0 0 0

SNSS Sunesis Pharmaceuticals Inc

Analysts Ratings for SNSS

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 1 1
Moderate Buy 0 0 0 0
Hold 3 3 5 5
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1

Brokerage Partners

SNSS Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs